The slippery superbug hiding in your gut that threatens the future of modern medicine

Nature · Published 3 October 2026 Swipe more like this →

In short: Klebsiella pneumoniae is a common, often harmless resident of the human gut, yet it is also a lethal pathogen. Protected by a thick, sugary shield, this bacterium is rapidly evolving to resist our most powerful antibiotics, causing 250,000 deaths annually and turning routine medical procedures into high-stakes risks.

Klebsiella belongs to the Enterobacteriaceae family, sharing a lineage with E. coli and Salmonella. While it is a natural inhabitant of the gut for over 2 billion people, it is also a versatile survivor found in soil, animals, and hospital infrastructure like sinks and bed rails. Its success stems from a remarkable ability to thrive on diverse nutrients and a specialized physical defense system. The bacterium is encased in a thick, slippery polysaccharide capsule that acts as a shield, effectively hiding it from the human immune system and preventing antibiotics from reaching their target.

The primary concern for global health is the bacterium's rapid acquisition of resistance genes. It frequently produces enzymes such as KPC, NDM, and OXA-48, which are capable of destroying carbapenems—a critical class of last-resort antibiotics. When these defenses are combined, mortality rates for infected patients can reach as high as 80%. According to the World Health Organization’s surveillance data, more than 55% of Klebsiella isolates globally are now resistant to third-generation cephalosporins, with some regions reporting figures exceeding 70%.

This resistance crisis is shifting the landscape of infection. Once considered a strictly hospital-acquired threat, Klebsiella is increasingly causing community-acquired infections in healthy individuals. Because few new antibiotics are currently in development, researchers are pivoting toward alternative strategies. These include host-directed therapies designed to bolster the patient’s own immune response and monoclonal antibodies that neutralize the specific factors the bacteria use to initiate infection. As the pathogen continues to evolve, the focus remains on rigorous infection control, such as improved hand hygiene and the careful stewardship of existing antibiotic supplies to prevent further escalation.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Klebsiella pneumoniae is a common soil dweller that can turn deadly in clinical settings.
• The antibiotic miracle is fading as bacteria evolve to outmanoeuvre our medicines
• Ancient proteins from the Jurassic period may defeat modern superbugs
• Why the medicine that saved millions is now becoming our greatest global health threat
• Can physics solve the crisis of drug-resistant superbugs?
• Koalas sleep twenty hours on a near-poison eucalyptus diet
• New Zealand’s kiwi smells prey with nostrils on its beak tip
• The Kodiak bear is a giant of the north, isolated for over 10,000 years.
• How a tiny antelope survives the African heat without drinking water
• Kodiak Island is a rugged Alaskan landscape shaped by ancient glaciers and volcanic ash.
• Is the humble kipper a culinary accident or a deliberate preservation masterpiece?
• Kohlrabi looks like a turnip but is really a swollen cabbage stem

More in Organisms · More in Nature · Latest · A–Z · All topics